Neurofibromatosis type 1: a multidisciplinary approach to care

AC Hirbe, DH Gutmann - The Lancet Neurology, 2014 - thelancet.com
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high
predisposition to develop both benign and malignant tumours. Although many …

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

C Carton, DG Evans, I Blanco, RE Friedrich… - …, 2023 - thelancet.com
Summary Background Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder,
predisposing development of benign and malignant tumours. Given the oncogenic potential …

Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis

Y Xing, Y Bronstein, MI Ross, RL Askew… - Journal of the …, 2011 - academic.oup.com
Background Meta-analyses were performed to examine the utility of ultrasonography,
computed tomography (CT), positron emission tomography (PET), and a combination of both …

Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version

T Nishida, S Hirota, A Yanagisawa, Y Sugino… - International journal of …, 2008 - Springer
Diagnostic and treatment strategies for gastrointestinal stromal tumors (GISTs) have evolved
greatly since the introduction of molecularly targeted therapies. Although several clinical …

Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study

WG Goettsch, SD Bos, N Breekveldt-Postma… - European journal of …, 2005 - Elsevier
Gastrointestinal stromal tumours (GIST) are identified by their specific morphology added
with immunohistochemical staining with anti-CD117, the phenotypic marker for GIST in the …

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of …

JY Blay, A Le Cesne, I Ray-Coquard, B Bui… - Journal of clinical …, 2007 - ascopubs.org
Purpose Imatinib is the standard treatment of advanced GI stromal tumors (GISTs). It is not
known whether imatinib may be stopped in patients in whom disease is controlled. Methods …

Combined surgical and molecular therapy: the gastrointestinal stromal tumor model

JS Gold, RP DeMatteo - Annals of surgery, 2006 - journals.lww.com
Objective: This review describes the pathologic and epidemiologic features of
gastrointestinal stromal tumor (GIST) as well as the contemporary management of this tumor …

[HTML][HTML] Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration

K Akahoshi, Y Sumida, N Matsui, M Oya… - World journal of …, 2007 - ncbi.nlm.nih.gov
AIM: To evaluate the role of endoscopic ultrasonography-guided fine needle aspiration
(EUS-FNA) in the preoperative diagnosis of gastrointestinal stromal tumor (GIST) …

[HTML][HTML] Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor

DH Koo, MH Ryu, KM Kim, HK Yang… - … : official journal of …, 2016 - synapse.koreamed.org
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors
originating in the gastrointestinal tract. With the introduction of molecular-targeted therapy for …

Nasopharyngeal carcinoma: the next challenges

ARA Razak, LL Siu, FF Liu, E Ito, B O'Sullivan… - European journal of …, 2010 - Elsevier
Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its aetiology,
epidemiology and potential therapeutic options. Despite cure for the majority of the patients …